PelliScope

AI-Powered Dermatological Decision Support

01 | The Product

Clinically-Validated AI
For Any Workflow

Ready to Deploy For

Pre-Medical Inquiry

Triage before the patient sees a doctor
Tele-Medicine Consultation

Cost-effective remote patient consultation
In-Patient Appointment Schedule

Prioritize urgency while sharing interim home care guidance

Patient Scan: #8829-A

ANALYSIS COMPLETE

Primary Detection

Herpes Zoster

74%

Confidence

Allergic Dermatitis59%

80.2% Accuracy on Technical Validation

Core Capabilities

Instant Clinical Support

Instantly distinguishes between infectious vs. non-infectious lesions to protect staff.

Diagnostic Assessment

Probability scoring for 10 common conditions (Eczema, Psoriasis, Tinea, etc.).

CPU-Optimized

Resource optimized for any hardware. On-premises deployable—data never leaves your control.

Operational Impact

Workflow Efficiency & Unit Economics

02 | Pre-Consultation Efficiency for Tele-Medicine

Workflow Comparison

+10 Patients / 5hr Shift

Traditional (No AI) 10 Min / Patient

Consultation (10m)

6 Patients / Hour

With PelliScope ~10 Min Total (Parallelized)

Preliminary
Diagnosis (3m)

Focused
Consult (7m)

AI triage saves 3 mins of discovery time per patient

8 Patients / Hour

Model Performance (AUC)

Zero-shot comparison on dermatology benchmarks

Grok-4

0.70

GPT-5

0.81

Gemini 2.5

0.82

PelliScope

0.86

Technical Accuracy: 80.2% Infectious vs Non-infectious flag

10-condition panel

Eczema, Allergic Contact Dermatitis, Insect Bite, Urticaria, Psoriasis, Folliculitis, Irritant Contact Dermatitis, Tinea, Herpes Zoster, Drug Rash.

Unit Economics (Daily)

Infrastructure Cost

$2.50

Daily Compute Spend (6 Hours)

Machine Specs

8 Core CPU

16 GB RAM

CPU Edge Inference

"A single machine costing less than a cup of coffee per day drives this entire workflow."

Clinical Revenue Gain

US & UAE Ready

$800+

Daily Additional Revenue

10+ Add. Patients

@ $80 avg. consult fee

Two-Level Screening

1

Infectious vs Non-Infectious

Immediate triage for Patient/User safety.

2

Differential Diagnosis

Top 10 most frequent skin conditions.

Commercial & Sovereign Economics

Pricing & Localization Strategy

Sovereign Data Adaptation

Targeting Any Demographics

Skin Foundation model will need to be caliberated, With an estimate dataset of atleast 500 images per disease class (so for 10 disease conditions = 5000 images)

Research & Development Fee

~$25k

One-Time Setup

Research Data Collection via Mobile App
AI Model Training & Validation
Tele Consultation Platform

Open Data Model

PELLISCOPE

Technical Report

$2.5k

Details on datasets used, training & testing methodologies on open source datasets, a complete route to Production model.

Tele-Medicine Platform Trial

$4k License for 6 months

Exclusive $0.50 per AI model query (Infectious Screen & Diagnostic Screen).

On-Premise Hospital Core

$15k / instance

Enterprise privacy; diagnostic models live within internal networks.

Hardware Resource Cost (6H Day) ~$2.50

Leadership

The PelliScope Team

04 | PelliScope Team

Vatsal Patel

Founder & Research Engineer

M.Sc Artificial Intelligence (IU Berlin)

Dr. Abhijeet Patel

Clinical Research Physician

Bachelor of Medicine & Surgery

Dr. Yash Patel

Clinical Research Physician

Bachelor of Medicine & Surgery

Dr. Nishi Seth

Consultant Dermatologist

M.D Dermatology

Saurav Roy

Operations Head

M.Tech Biotechnology

Ananya Pal

Finance & Accounting Head

B.S Economics

Vision & Portfolio

How HawkFranklin Operates

Operational Revenue Model

Path A: HFR-Initiated Products

We identify a market gap, build a validated product (like PelliScope), and then seek commercial partners to scale it.

Path B: Partner-Initiated R&D

You bring a defined challenge. We build the dedicated AI solution, acting as your external deep-tech R&D team.

Our Philosophy

HawkFranklin’s long-term vision is to innovate science with commercial rigor. Our team spans physicists, chemists, biologists, and AI engineers who are building breakthroughs across quantum computing, finance, and healthcare.

"We are a resilient, self-funded team. We are not an IT/AI company; we work towards converting cutting-edge research into valued products that can be integrated into society."

Broader Biomedical Portfolio

OncoGemma

AI agents for digital pathology analysis

C-Risq

Multi-omics for cancer risk stratification

MedDiscover

RAG copilot for biomedical Q&A

Clinical FM

Foundation models for tabular EHR data

Beyond PelliScope, we maintain specialist pods across these domains to spin up commercialization-ready products wherever the science demands it.